STEPHEN ROCAMBOLI - 26 May 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 16:13:38 UTC
Previous filing
17 May 2022
Next filing
30 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 26 May 2022 Common Stock 40,000 $5.51 Direct F1
transaction ESPR Stock Option (right to buy) Award $0 +1,589 $0.000000 1,589 26 May 2022 Common Stock 1,589 $5.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest over a three (3) year period in equal annual installments, the first of which will be May 26, 2023.
F2 The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.